Per-Se Technologies has appointed Philip Pead president and CEO following the abrupt departure of Allen Ritchie. Pead also assumes Ritchie's spot on the company's board of directors. Pead joined Per-Se in 1997 and most recently held the
Per-Se Technologies has appointed Philip Pead president and CEO following the abrupt departure of Allen Ritchie. Pead also assumes Ritchie's spot on the company's board of directors. Pead joined Per-Se in 1997 and most recently held the positions of executive vice president and COO for the firm. Per-Se provides business management services to physicians and claims to support 35,000 physicians and 2000 healthcare organizations.
© 2000 Miller Freeman Inc.
11/29/00, Issue # 117, page 5.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.